JLVRX
Price
$20.12
Change
+$0.07 (+0.35%)
Updated
Jun 18 closing price
Net Assets
4.96B
VIVAX
Price
$67.52
Change
+$0.12 (+0.18%)
Updated
Jun 18 closing price
Net Assets
188.77B
Interact to see
Advertisement

JLVRX vs VIVAX

Header iconJLVRX vs VIVAX Comparison
Open Charts JLVRX vs VIVAXBanner chart's image
JPMorgan Large Cap Value R5
Price$20.12
Change+$0.07 (+0.35%)
VolumeN/A
Net Assets4.96B
Vanguard Value Index I
Price$67.52
Change+$0.12 (+0.18%)
VolumeN/A
Net Assets188.77B
JLVRX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JLVRX vs. VIVAX commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLVRX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. JLVRX (4.96B). VIVAX pays higher dividends than JLVRX: VIVAX (2.16) vs JLVRX (1.36). JLVRX was incepted earlier than VIVAX: JLVRX (19 years) vs VIVAX (33 years). JLVRX (0.61) is less costly to investors than VIVAX (0.17). JLVRX is a more actively managed with annual turnover of: 167.00 vs. VIVAX (9.00). JLVRX has a lower initial minimum investment than VIVAX: JLVRX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 6.93 vs. JLVRX (1.45). VIVAX return over 5 years is better than : 70.82 vs. JLVRX (66.10).
JLVRXVIVAXJLVRX / VIVAX
Total Expense Ratio0.540.17318%
Annual Report Gross Expense Ratio0.610.17359%
Fund Existence19 years33 years-
Gain YTD1.1602.23752%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.96B189B3%
Annual Yield % from dividends1.362.1663%
Returns for 1 year1.456.9321%
Returns for 3 years20.2435.4557%
Returns for 5 years66.1070.8293%
Returns for 10 years48.74103.3047%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKBA3.560.06
+1.71%
Akebia Therapeutics
PCH38.350.64
+1.70%
PotlatchDeltic Corp
ARES167.342.16
+1.31%
Ares Management Corp
STXS2.26-0.01
-0.44%
Stereotaxis
XTIA3.51-0.59
-14.39%
XTI Aerospace Inc